Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes a 6-month randomized placebo-controlled dose-response study

To evaluate the efficacy and safety of four doses of pioglitazone monotherapy in the treatment of patients with type 2 diabetes. There were 408 patients randomized in this multicenter double-blind placebo-controlled clinical trial. Patients who had HbA1c > or = 7.0%, fasting plasma glucose (FPG)...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes care 2000-11, Vol.23 (11), p.1605-1611
Hauptverfasser:	ARONOFF, Stephen, ROSENBLATT, Sid, BRAITHWAITE, Susan, EGAN, John W, MATHISEN, Annette L, SCHNEIDER, Roberta L
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences General and cellular metabolism. Vitamins Medical sciences Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!